Close

Northwest Biotherapeutics (NWBO) Announces DCVax-L + Keytruda Combo Phase in Colorectal Cancer

Go back to Northwest Biotherapeutics (NWBO) Announces DCVax-L + Keytruda Combo Phase in Colorectal Cancer
NORTHWEST BIO (AMEX: NWBO) Delayed: 0.48 +0.02 (4.35%)
Previous Close $0.46    52 Week High $5.19 
Open $0.47    52 Week Low $0.32 
Day High $0.49    P/E N/A 
Day Low $0.46    EPS $-3.72 
Volume 1,098,120